Your browser doesn't support javascript.
loading
The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial.
Zhao, Jimmy L; Fizazi, Karim; Saad, Fred; Chi, Kim N; Taplin, Mary-Ellen; Sternberg, Cora N; Armstrong, Andrew J; de Bono, Johann S; Duggan, William T; Scher, Howard I.
Afiliação
  • Zhao JL; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Fizazi K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Saad F; Department of Cancer Medicine at Institut Gustave Roussy, Villejuif, France.
  • Chi KN; Department of GU Oncology, University of Montreal Hospital Centre (CHUM), Montreal, Canada.
  • Taplin ME; Vancouver Prostate Centre, Vancouver, Canada.
  • Sternberg CN; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Armstrong AJ; Englander Institute for Precision Medicine, Sandra and Edward Meyer Cancer Center, New York, New York.
  • de Bono JS; Medical Oncology, Duke Cancer Center, Durham, North Carolina.
  • Duggan WT; The Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom.
  • Scher HI; Pfizer Inc., Groton, Connecticut.
Clin Cancer Res ; 28(5): 860-869, 2022 Mar 01.
Article em En | MEDLINE | ID: mdl-34965947
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article